![Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial - Journal of Allergy and Clinical Immunology Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/be89b4d6-117a-4c9f-b27c-495fa74a51e0/gr1.jpg)
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial - Journal of Allergy and Clinical Immunology
![A protocol for a single-center, single-blinded randomized-controlled trial investigating volar plating versus conservative treatment of unstable distal radius fractures in patients older than 65 years | BMC Musculoskeletal Disorders | Full Text A protocol for a single-center, single-blinded randomized-controlled trial investigating volar plating versus conservative treatment of unstable distal radius fractures in patients older than 65 years | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12891-019-2677-y/MediaObjects/12891_2019_2677_Fig1_HTML.png)
A protocol for a single-center, single-blinded randomized-controlled trial investigating volar plating versus conservative treatment of unstable distal radius fractures in patients older than 65 years | BMC Musculoskeletal Disorders | Full Text
![Randomised, single-blind, parallel design of the study. Patients were... | Download Scientific Diagram Randomised, single-blind, parallel design of the study. Patients were... | Download Scientific Diagram](https://www.researchgate.net/publication/316054519/figure/fig2/AS:482446903910402@1492035713577/Randomised-single-blind-parallel-design-of-the-study-Patients-were-included-and.png)
Randomised, single-blind, parallel design of the study. Patients were... | Download Scientific Diagram
![Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial - The Lancet Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2085215509/2073775688/gr1.gif)
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial - The Lancet
![A multicenter, single-blind randomized controlled trial of endoscopic clipping closure for preventing coagulation syndrome after colorectal endoscopic submucosal dissection - Gastrointestinal Endoscopy A multicenter, single-blind randomized controlled trial of endoscopic clipping closure for preventing coagulation syndrome after colorectal endoscopic submucosal dissection - Gastrointestinal Endoscopy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/22804926-e5c6-44ec-b401-f2ebd85ef593/gr1.jpg)